{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-081575","form_type":"8-K","ticker":"ALLR","cik":"0001860657","company_name":"Allarity Therapeutics, Inc.","filed_at":"2023-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.157831+00:00","generated_at":"2026-06-09T06:14:44.096442+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Allarity Therapeutics faces Nasdaq delisting after bid price below $1 for 30 days; cumulative reverse split ratio >250:1","bullets":["Received Nasdaq notice Oct 27, 2023: bid price below $1 for 30 consecutive business days.","Effected 1:35 reverse stock split on Mar 24, 2023 and 1:40 on Jun 28, 2023; cumulative ratio >250:1.","Not eligible for 180-day compliance period due to prior reverse splits; delisting unless appeal is requested.","Company intends to appeal; stock continues trading during appeal; delisting effective Nov 7, 2023 if no appeal."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-081575","json":"https://secwatch.observer/filing/0001213900-23-081575.json","markdown":"https://secwatch.observer/filing/0001213900-23-081575.md","text":"https://secwatch.observer/filing/0001213900-23-081575.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860657/000121390023081575/0001213900-23-081575-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860657/000121390023081575/ea187416-8k_allarity.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T06:14:44.096442+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"535f87b9c2cbe3a0b83a5c509ce4516ba6261c32","claim":"Allarity Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv)).","evidence_excerpt":"October 27, 2023, we received notification from the Nasdaq Listing Qualifications staff that it has determined that the bid price of our Common Stock has closed at less than $1 per share over the previous 30 consecutive business days, and, as a result, does not comply with Listing Rule 5550(a)(2) (the “Rule”). Further, the staff also noted that we effected an 1:35 reverse stock split on March 24, 2023, and an 1:40 reverse stock split on June 28, 2023. Because we effected one or more reverse stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one, we wil","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1860657/000121390023081575/0001213900-23-081575-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2), 5810(c)(3)(A)(iv)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}